Genetic changes associated with the acquisition of androgen-independent growth, tumorigenicity and metastatic potential in a prostate cancer model.
about
Changes in extracellular matrix (ECM) and ECM-associated proteins in the metastatic progression of prostate cancerDistribution of IGFBP-rP1 in normal human tissuesLoss of heterozygosity and lack of mutations of the XPG/ERCC5 DNA repair gene at 13q33 in prostate cancer.Human prostate fibroblasts induce growth and confer castration resistance and metastatic potential in LNCaP CellsCoevolution of prostate cancer and bone stroma in three-dimensional coculture: implications for cancer growth and metastasis.Establishing human prostate cancer cell xenografts in bone: induction of osteoblastic reaction by prostate-specific antigen-producing tumors in athymic and SCID/bg mice using LNCaP and lineage-derived metastatic sublines.Human prostate cancer risk factors.Cytogenetic and expression profiles associated with transformation to androgen-resistant prostate cancer.Chromosomal aberrations related to metastasis of human solid tumorsGenetic alterations in hormone-refractory recurrent prostate carcinomasAccumulation of genetic changes is associated with poor prognosis in grade II astrocytomas.Molecular pathology of prostate cancer.Inhibition of hedgehog and androgen receptor signaling pathways produced synergistic suppression of castration-resistant prostate cancer progression.Prostate cancer cells use genetic and epigenetic mechanisms for progression to androgen independence.ID1-, ID2-, and ID3-regulated gene expression in E2A positive or negative prostate cancer cells.The impact of genomic alterations on the transcriptome: a prostate cancer cell line case study.MUC1 expression in human prostate cancer cell lines and primary tumors.Chromosomal aberrations in prostate cancer xenografts detected by comparative genomic hybridization.LNCaP progression model of human prostate cancer: androgen-independence and osseous metastasis.Molecular cytogenetic studies of a serially transplanted primary prostatic carcinoma xenograft (CWR22) and four relapsed tumors.Switch from antagonist to agonist of the androgen receptor bicalutamide is associated with prostate tumour progression in a new model system.Antiandrogen withdrawal syndrome and alternative antiandrogen therapy associated with the W741C mutant androgen receptor in a novel prostate cancer xenograft.The TMPRSS2 gene encoding transmembrane serine protease is overexpressed in a majority of prostate cancer patients: detection of mutated TMPRSS2 form in a case of aggressive disease.DNA copy number alterations in prostate cancers: a combined analysis of published CGH studies.Genetic mapping of allelic loss on chromosome 6q within heterogeneous prostate carcinoma.
P2860
Q24807354-4C689F4E-F63F-4678-A2BD-A77F3C774C9EQ28144863-28FF02BD-52C3-4EA0-AA42-DAC88D3810D1Q30304332-A4DC7D81-F933-476C-8DC5-B98A8A7655C7Q30431576-AB8B8154-916F-4CB8-928C-E60EBBF4B539Q30432069-08573F8C-7431-4A5F-A32A-610D60E25226Q30472489-C95A16EF-15E6-4627-A39D-49869EF0ACC4Q34360616-79F4F93E-EF98-41DA-A28E-691CFA772DF2Q34452318-33BDDFBB-CE83-44A3-B90E-E4BC32521319Q34961715-B339A621-938F-40E5-B933-639F5ECA19F0Q35753171-3EF8AB93-92C2-46F5-ADE5-7127262EF197Q35764885-25377444-CE9A-4493-948C-5457DBC506E5Q36249264-9E791347-D258-4801-AD58-1EE9EF61B9B8Q37325266-1C7C7251-D514-4D27-95EA-9A32C827045CQ38314252-B14A94BF-5BC5-40A3-A627-D4B1D1B6E928Q40105246-3B380779-68D5-43F2-A320-0E6BFAEC5731Q40258450-FF4D907E-63C1-40B5-805B-DDE5BF8502F9Q40505299-F5398121-7845-4D18-ADEF-53C643033942Q40707535-6BBD330B-2A9A-4439-816A-DBDB06136822Q40869882-8422633A-50B1-411A-AB92-2EE2D420F74AQ40936629-CDD593C2-4503-49FE-B304-A4FFC54CE212Q41827081-63748276-9871-4082-ADB6-245C6A343E27Q43269331-3B6EC61B-1695-4DA1-8B2E-BEFD078028DFQ43824461-6ADE6333-4A98-4B95-AE3E-A7EEE9A40C83Q48081055-960436C7-0D69-4702-B831-AE689F3FF7C9Q53376016-0DDF36DA-C7FF-4DF0-A3BC-548662EB4825
P2860
Genetic changes associated with the acquisition of androgen-independent growth, tumorigenicity and metastatic potential in a prostate cancer model.
description
1997 nî lūn-bûn
@nan
1997 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Genetic changes associated wit ...... al in a prostate cancer model.
@ast
Genetic changes associated wit ...... al in a prostate cancer model.
@en
type
label
Genetic changes associated wit ...... al in a prostate cancer model.
@ast
Genetic changes associated wit ...... al in a prostate cancer model.
@en
prefLabel
Genetic changes associated wit ...... al in a prostate cancer model.
@ast
Genetic changes associated wit ...... al in a prostate cancer model.
@en
P2093
P2860
P356
P1476
Genetic changes associated wit ...... al in a prostate cancer model.
@en
P2093
E R Hyytinen
G N Thalmann
T Visakorpi
P2860
P2888
P304
P356
10.1038/BJC.1997.32
P407
P577
1997-01-01T00:00:00Z
P5875
P6179
1017533502